January 29, 2021 Deborah Wenkert, MD Dear Debbie:Inozyme Pharma, Inc. • March 25th, 2021 • Pharmaceutical preparations • California
On behalf of Inozyme Pharma Inc. (the “Company”), I am pleased to offer you employment with the Company, commencing on February 2, 2021 (the “Effective Date”). Until the Effective Date, the Consulting Agreement, dated October 29, 2020, by and between the Company and Wenkert & Young, LLC (the “Consulting Agreement”), will remain in full force and effect and continue to govern your provision of services to the Company and you and the Company mutually agree that the Consulting Agreement will terminate on the Effective Date. This letter agreement (the “Letter Agreement”) sets forth the terms of your employment with the Company, should you accept our offer.
March 24, 2021 Stephen Basso Dear Stephen:Original Letter Agreement • March 25th, 2021 • Inozyme Pharma, Inc. • Pharmaceutical preparations • Massachusetts
This letter (the “Letter Agreement”) amends and restates the terms and conditions of your employment with Inozyme Pharma, Inc. (“Inozyme” or the “Company”), as set forth in your letter agreement dated June 30, 2020 (the “Original Letter Agreement”), and will be effective as of March 24, 2021 (the “Effective Date”), provided that you remain employed by the Company as of the Effective Date. Until the Effective Date, the Original Letter Agreement will remain in full force and effect and continue to govern your employment with the Company. This Letter Agreement contains the following terms:
Employment contractEmployment Contract • March 25th, 2021 • Inozyme Pharma, Inc. • Pharmaceutical preparations
WHEREAS, Inozyme Pharma, Inc, 321 Summer Street, Suite 400 Boston, MA 02210, USA, (the “Parent”) and the Employee have concluded an employment agreement on 30 June 2020 (the “Prior Employment Agreement”);
